CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Mitochondrial transfer in tunneling nanotubes-a new target for cancer therapy.
Mitochondrial transfer in tunneling nanotubes-a new target for cancer therapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
一个世纪前,Warburg 效应首次提出,揭示癌细胞在肿瘤发生过程中即使处于氧气充足环境,也主要依赖糖酵解,使能量代谢的主要途径从三羧酸循环转向有氧糖酵解。近期研究揭示肿瘤微环境中线粒体的动态转移,不仅发生于肿瘤细胞之间,也发生于肿瘤细胞与基质细胞、免疫细胞等之间。本综述探讨肿瘤微环境中线粒体转移的途径和机制,以及这些转移活动如何促进肿瘤侵袭性、化疗耐药和免疫逃逸。此外,我们讨论了靶向这些现象的研究进展及潜在临床意义,并强调靶向细胞间线粒体转移作为未来抗癌策略、增强细胞介导免疫治疗的潜在治疗价值。
A century ago, the Warburg effect was first proposed, revealing that cancer cells predominantly rely on glycolysis during the process of tumorigenesis, even in the presence of abundant oxygen, shifting the main pathway of energy metabolism from the tricarboxylic acid cycle to aerobic glycolysis.
Recent studies have unveiled the dynamic transfer of mitochondria within the tumor microenvironment, not only between tumor cells but also between tumor cells and stromal cells, immune cells, and others. In this review, we explore the pathways and mechanisms of mitochondrial transfer within the tumor microenvironment, as well as how these transfer activities promote tumor aggressiveness, chemotherapy resistance, and immune evasion.
Further, we discuss the research progress and potential clinical significance targeting these phenomena.
We also highlight the therapeutic potential of targeting intercellular mitochondrial transfer as a future anti-cancer strategy and enhancing cell-mediated immunotherapy.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。